-- BorgWarner, Goodyear, Lululemon, Regeneron, Tiffany: U.S. Equity Movers
-- B y   I n y o u n g   H w a n g
-- 2012-01-10T21:31:27Z
-- http://www.bloomberg.com/news/2012-01-09/alcoa-cirrus-logic-juniper-liz-claiborne-u-s-equity-preview.html
Shares of the following companies
had unusual moves in U.S. market trading. Stock symbols are in
parentheses, and prices are as of 4 p.m. in  New York .  Index changes:  Carter’s Inc. (CRI)  , the maker of
children’s clothes, will replace  99 Cents Only Stores  (NDN US)
in the S&P MidCap 400 Index after the close on Jan. 13, while
 Virtus Investment Partners Inc. (VRTS)   will take Carter’s
place in the S&P SmallCap 600 Index, S&P said.  SunCoke Energy Inc. (SXC)  (SXC US) will replace  School Specialty
Inc. (SCHS)   in the S&P SmallCap 600 Index after the close of
trading on Jan. 17, S&P said in a statement.  Carter’s rose 2.9 percent to $41.54. Virtus advanced 7.3
percent to $82.88. School Specialty declined 4.4 percent to
$2.40.  Audiovox Corp. (VOXX)   gained the most since May 2009,
advancing 21 percent to $10.89. The maker of automotive and
consumer electronics posted third-quarter sales and earnings
that exceeded the single estimate in a Bloomberg survey, and
forecast annual earnings higher than the average of two
projections.  BorgWarner Inc. (BWA)   climbed 12 percent, the biggest
gain the Standard & Poor’s 500 Index, to $72.25. The maker of
turbochargers forecast profit this year will be $5.35 to $5.65 a
share. That tops the $5.17 average estimate of 19 analysts
tracked by Bloomberg.  Charles River Laboratories International Inc. (CRL)  
advanced 17 percent, the second-most in the Russell 1000 Index,
to $32.47. The medical research company will probably be broken
up in a sale, with the research models and services group going
to a private equity firm, and preclinical business getting a
strategic buyer, according to Sterne Agee & Leach Inc.  Cirrus Logic Inc. (CRUS)   surged 16 percent, the most
since Jan. 27, to $19.64. The supplier of parts for  Apple Inc.’s (AAPL) 
 iPhone and iPad forecast fourth-quarter revenue of
$105 million, above the average analyst estimate of $98.5
million.  Complete Genomics Inc. (GNOM)   dropped 24 percent, the
most since Aug. 4, to $2.94. The  Mountain View , California-based
human genome sequencing company was cut to “market perform”
from “outperform” at Oppenheimer & Co.  DSW Inc. (DSW)   jumped 13 percent, the most since May 24,
to $48.11. The shoe retailer lifted its full-year earnings
forecast and said it will accelerate store openings this year.  Eastman Kodak Co. (EK)   gained the most in the Russell
2000 Index, advancing 50 percent to 60 cents. The unprofitable
131-year-old imaging company simplified its management structure
and created a chief operating office to reduce costs.  Emulex Corp. (ELX)   rose 13 percent, the most since April
2009, to $8.37. The chipmaker forecast second-quarter earnings
of at least 24 cents a share. Analysts projected 17 cents a
share, according to the average estimate in a Bloomberg survey.  Francesca’s Holdings Corp. (FRAN)   rallied 12 percent,
the most since Dec. 7, to $20.31. The Houston, Texas-based
women’s apparel retailer raised its fourth-quarter earnings
forecast to 16 cents a share to 17 cents a share from an earlier
estimate of 14 cents to 15 cents. Analysts projected 15 cents a
share on average.  Goodyear Tire & Rubber Co.  (GT US) dropped 8.3 percent, the
most since Aug. 18, to $14.01. The largest U.S. tiremaker said
it’s experiencing softness in global demand.  Health Management Associates Inc. (HMA)   fell the second-
most in the Russell 1000 Index, sliding 13 percent to $6.05.
Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised
concerns about an October whistle-blower lawsuit against the
operator of acute-care hospitals involving Medicare billing. The
suit was filed by a former Health Management employee named Paul
Meyer, who has “long experience” investigating Medicare fraud,
Skolnick said.  Hi-Tech Pharmacal Co. (HITK)   dropped 16 percent, the
most since March 2, to $35.31. Wockhardt Ltd. (WPL IN) said it
won Food and Drug Administration approval for generic copy of
GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to
introduce the drug immediately. Hi-Tech, the Amityville, New
York-based prescription and over-the-counter pharmaceuticals
company, sells generic copies of the nasal spray.  Lexicon Pharmaceuticals Inc. (LXRX)   rose 9.5 percent,
the most since Dec. 30, to $1.27. The biotechnology company said
the combination of LX4211 and the DPP-4 drug reduced blood sugar
after meals in type 2 diabetes patients more than the DPP-4
inhibitor did on a stand-alone basis.  Life Technologies Corp. (LIFE)   rose the second-most in
the  S&P 500 , climbing 8.3 percent to $46.17. The provider of
gene-analysis tools said it’s taking orders for the new benchtop
Ion Proton Sequencer, designed to sequence the entire human
genome in a day for $1,000.  Illumina Inc. (ILMN)  , which offers a competing product,
HiSeq, rose 3.7 percent to $33.01.  Liz Claiborne Inc. (LIZ)   tumbled 13 percent, the biggest
drop since Aug. 8, to $8.64. The apparel maker cut its profit
forecast for the coming year and said its chief financial
officer is departing.  Lululemon Athletica Inc. (LULU)   rose 12 percent, the
most since December 2010, to $59.87. The yoga-wear retailer
forecast fourth-quarter earnings of 47 cents a share to 49 cents
a share, topping the average analyst estimate of 42 cents a
share.  Regeneron Pharmaceuticals Inc. (REGN)   increased 14
percent, the most since April 27, to $74.44. Fourth-quarter net
sales for the company’s Eylea drug for wet age-related macular
degeneration, a blindness-causing eye disorder, were more than
four times what Cowen & Co. estimated.  Signet Jewelers Ltd. (SIG)   declined 6.3 percent, the
most since Aug. 18, to $44.05. The company forecast 2012
earnings of no more than $3.72 a share, below the average
analyst estimate of $3.74 a share.  Tiffany & Co.  (TIF US) fell 10 percent, the most in the S&P
500, to $59.94. The world’s second-largest luxury jewelry
retailer reduced its annual earnings forecast after volatile
stock markets slowed holiday sales growth.  WebMD Health Corp. (WBMD)   sank 29 percent, the most
since July 18, to $26.25. The medical-information company said
it terminated discussions with potential acquirers and that
Wayne Gattinella resigned as chief executive officer.  To contact the reporter on this story:
Inyoung Hwang in New York at 
 ihwang7@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  